rs141401803

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP3BS2_Supporting

The NM_000238.4(KCNH2):​c.2860C>T​(p.Arg954Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000468 in 1,580,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000048 ( 0 hom. )

Consequence

KCNH2
NM_000238.4 missense

Scores

7
6
6

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6O:1

Conservation

PhyloP100: 1.38
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.783
BS2
High AC in GnomAd4 at 6 AD,Digenic gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNH2NM_000238.4 linkc.2860C>T p.Arg954Cys missense_variant 12/15 ENST00000262186.10 NP_000229.1 Q12809-1Q15BH2A0A090N8Q0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNH2ENST00000262186.10 linkc.2860C>T p.Arg954Cys missense_variant 12/151 NM_000238.4 ENSP00000262186.5 Q12809-1
KCNH2ENST00000330883.9 linkc.1840C>T p.Arg614Cys missense_variant 8/111 ENSP00000328531.4 Q12809-2
KCNH2ENST00000684241.1 linkn.3693C>T non_coding_transcript_exon_variant 10/13

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152156
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000375
AC:
7
AN:
186632
Hom.:
0
AF XY:
0.0000390
AC XY:
4
AN XY:
102580
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000349
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000385
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000629
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000476
AC:
68
AN:
1428058
Hom.:
0
Cov.:
36
AF XY:
0.0000410
AC XY:
29
AN XY:
708030
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000249
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000484
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000556
Gnomad4 OTH exome
AF:
0.0000338
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152156
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74320
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000882
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000113
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000255
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long QT syndrome Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthMay 14, 2024This missense variant replaces arginine with cysteine at codon 954 of the KCNH2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Experimental functional studies have shown this variant may reduce ionic current and accelerate channel deactivation (PMID: 17210839, 18222468, 18675227). This variant has been reported in individuals affected with sudden infant death syndrome (PMID: 17210839), drug-induced QT prolongation (PMID: 18675227), atrial fibrillation (Han et al., 2010), sudden unexplained death (PMID: 27930701), and sudden death suspected of being an inherited arrhythmogenic syndrome (PMID: 32268277). This variant has also been identified in 8/217960 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 16, 2024This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 954 of the KCNH2 protein (p.Arg954Cys). This variant is present in population databases (rs141401803, gnomAD 0.005%). This missense change has been observed in individuals with KCNH2-related conditions and/or Long QT (PMID: 17210839, 18675227, 27930701; Invitae). ClinVar contains an entry for this variant (Variation ID: 67444). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 17210839, 18222468, 18675227). This variant disrupts the p.Arg954 amino acid residue in KCNH2. Other variant(s) that disrupt this residue have been observed in individuals with KCNH2-related conditions (PMID: 27026747), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 17, 2024Variant summary: KCNH2 c.2860C>T (p.Arg954Cys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.7e-05 in 186996 control chromosomes. c.2860C>T has been reported in the literature in individuals affected with clinical features of KCNH2-related conditions, including SIDS (e.g., Arnestad_2007) and drug-induced arrhythmia and/or prolonged QT (e.g, Biliczki_2008, Behr_2013). These data indicate that the variant may be associated with disease. At least two publications suggest the variant inhibits biophyisical properties (e.g., Biliczki_2008, Rhodes_2008). The following publications have been ascertained in the context of this evaluation (PMID: 17210839, 18222468, 18675227, 24223155). ClinVar contains an entry for this variant (Variation ID: 67444). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxMar 31, 2022Observed in individuals with sudden infant death syndrome (SIDS) or sudden unexpected death (SUD) (Arnestad et al., 2007; Sanchez et al., 2016); Also reported in an individual with an increased QTc interval during macrolide treatment that normalized after drug withdrawal, as well as in her daughter who had a QTc of approximately 450ms (Biliczki et al., 2008); Published functional studies demonstrate a damaging effect as this variant results in reduced channel current and significant alterations in channel biophysical properties (Rhodes et al., 2008; Biliczki et al., 2008); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 21778721, 23304551, 24223155, 21215473, 28316956, 26633542, 27026747, 18675227, 27930701, 34502138, 22581653, 32048431, 32268277, 17210839, 31043699, 18222468) -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 04, 2019The c.2860C>T (p.R954C) alteration is located in exon 12 (coding exon 12) of the KCNH2 gene. This alteration results from a C to T substitution at nucleotide position 2860, causing the arginine (R) at amino acid position 954 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Cardiac arrhythmia Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthJan 20, 2023This missense variant replaces arginine with cysteine at codon 954 of the KCNH2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Experimental functional studies have shown this variant may reduce ionic current and accelerate channel deactivation (PMID: 17210839, 18222468, 18675227). This variant has been reported in individuals affected with sudden infant death syndrome (PMID: 17210839), drug-induced QT prolongation (PMID: 18675227), and atrial fibrillation (Han et al., 2010). This variant has also been identified in 8/217960 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
SUDDEN INFANT DEATH SYNDROME Other:1
not provided, no classification providedliterature onlyCardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust-This variant has been reported as associated with Sudden infant death syndrome in the following publications (PMID:17210839;PMID:18675227). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Pathogenic
0.35
D
BayesDel_noAF
Pathogenic
0.41
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.46
.;T
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Benign
0.56
D
LIST_S2
Uncertain
0.92
D;D
M_CAP
Pathogenic
0.74
D
MetaRNN
Pathogenic
0.78
D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Benign
0.69
.;N
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
-1.5
N;N
REVEL
Pathogenic
0.67
Sift
Uncertain
0.023
D;D
Sift4G
Benign
0.10
T;T
Polyphen
1.0
D;D
Vest4
0.60
MVP
0.99
MPC
0.62
ClinPred
0.22
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
3.2
Varity_R
0.18
gMVP
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141401803; hg19: chr7-150644799; API